1. Home
  2. TIL vs TEAF Comparison

TIL vs TEAF Comparison

Compare TIL & TEAF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TIL
  • TEAF
  • Stock Information
  • Founded
  • TIL 2018
  • TEAF 2017
  • Country
  • TIL United States
  • TEAF United States
  • Employees
  • TIL N/A
  • TEAF N/A
  • Industry
  • TIL Biotechnology: Pharmaceutical Preparations
  • TEAF Trusts Except Educational Religious and Charitable
  • Sector
  • TIL Health Care
  • TEAF Finance
  • Exchange
  • TIL Nasdaq
  • TEAF Nasdaq
  • Market Cap
  • TIL 171.7M
  • TEAF 174.8M
  • IPO Year
  • TIL 2021
  • TEAF N/A
  • Fundamental
  • Price
  • TIL $22.12
  • TEAF $12.07
  • Analyst Decision
  • TIL Strong Buy
  • TEAF
  • Analyst Count
  • TIL 4
  • TEAF 0
  • Target Price
  • TIL $114.00
  • TEAF N/A
  • AVG Volume (30 Days)
  • TIL 83.9K
  • TEAF 56.1K
  • Earning Date
  • TIL 03-20-2025
  • TEAF 01-01-0001
  • Dividend Yield
  • TIL N/A
  • TEAF 9.20%
  • EPS Growth
  • TIL N/A
  • TEAF N/A
  • EPS
  • TIL N/A
  • TEAF N/A
  • Revenue
  • TIL N/A
  • TEAF N/A
  • Revenue This Year
  • TIL N/A
  • TEAF N/A
  • Revenue Next Year
  • TIL N/A
  • TEAF N/A
  • P/E Ratio
  • TIL N/A
  • TEAF N/A
  • Revenue Growth
  • TIL N/A
  • TEAF N/A
  • 52 Week Low
  • TIL $9.62
  • TEAF $11.11
  • 52 Week High
  • TIL $92.00
  • TEAF $13.30
  • Technical
  • Relative Strength Index (RSI)
  • TIL 48.67
  • TEAF 42.32
  • Support Level
  • TIL $19.00
  • TEAF $12.11
  • Resistance Level
  • TIL $25.80
  • TEAF $12.28
  • Average True Range (ATR)
  • TIL 2.19
  • TEAF 0.10
  • MACD
  • TIL 0.22
  • TEAF -0.00
  • Stochastic Oscillator
  • TIL 45.88
  • TEAF 24.73

About TIL Instil Bio Inc.

Instil Bio Inc is a clinical-stage biopharmaceutical company focused on developing a cell therapy pipeline of autologous tumor infiltrating lymphocyte, or TIL, therapies for the treatment of patients with cancer. It is also engaged in developing a novel class of genetically engineered TIL therapies using its Co-Stimulatory Antigen Receptor, or CoStAR, platform. Its pipeline includes ITIL-306 which expresses a CoStAR molecule designed to recognize FRα, a tumor-associated antigen that is expressed on numerous solid tumors, including ovarian cancer, uterine cancer, NSCLC, and renal cancer.

About TEAF Ecofin Sustainable and Social Impact Term Fund

Tortoise Essential Assets Income Term is a US-based non-diversified, closed-end management investment company. Its investment objective is to provide common shareholders with a high level of total return with an emphasis on current distributions.

Share on Social Networks: